Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

US-based biotechnology company Rallybio has dosed the first subject in a Phase II trial evaluating RLYB212 as a potential ...

The Korea Food and Drug Administration announced on the 20th that it has approved the adult immune thrombocytopenia treatment 'Tavalisse' (ingredient name fostamatinib), developed by the American ...

A typical platelet count range can change with age. Platelet counts may fluctuate due to natural vascular aging, changes in bone marrow tissue, and altered blood plasma makeup. Platelets ...

The Ministry of Food and Drug Safety approved the prescription of Tavalisse for adult patients who have not responded well to existing treatments. Chronic immune thrombocytopenia is an autoimmune ...

Living with this chronic platelet disorder is linked to stress, anxiety, and depression, but these tips can help.

[2] In 1998 only one drug in this class was available, a monoclonal antibody (abciximab) directed against the fibrinogen receptor on the platelet surface GP IIb/IIIa. A more recently approved drug ...

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

The pathogenesis of suboptimal platelet function is multifactorial. Platelets do not function well if there are too many or too few platelets; also the platelets can be present in the appropriate ...

Platelet-Coupled IL-2 Cell Injection is under clinical development by Zcapsule Pharmaceuticals (Shaoxing) and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid ...

Based on this feature of DBCM, we developed a new platelet functional assay that allows for the evaluation of the pharmacological effects of antiplatelet drugs. It is advantageous, as it detects the ...

and hematology drugs (Dova's platelet drug Doptelet, ADC's blood cancer drug Zynlonta, and CTI's Vonjo) help bolster long-term growth prospects. We think Sobi is taking the right steps to ...